{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:43:44Z","timestamp":1793277824006,"version":"4.5.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Rheumatoid arthritis (RA) is a common chronic autoimmune disease that contributes to progressive disability, systemic complications, higher mortality, and societal burden. Typical symptoms of RA include symmetrical pain and swelling in multiple joints, morning stiffness, and elevated levels of erythrocyte sedimentation rate, C-reactive protein, and rheumatoid factor. The representative treatment for RA is medication, including disease-modifying antirheumatic drugs, glucocorticoids, and nonsteroidal anti-inflammatory drugs. However, these medications are not yet curative nor preventative and are associated with several adverse effects, leading to their discontinuation. Recent articles reported that Simiao Xiaobi decoction (SXD) could relieve the symptoms of RA by clinical trial and experimental study, but an evidence-based review on the effectiveness and safety of SXD on RA has not yet been provided.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Searching for randomized controlled trials on the use of SXD for RA will be performed by using multiple electronic databases, manual search, and contacting the authors by e-mail if needed. Studies will be selected according to the predefined criteria and the data collected on study participants, interventions, control groups, outcome measurements, their results, adverse events, and risk of bias will be summarized. The primary outcome will be the disease activity score (including effective rate, swollen joint count, tender joint count, and morning stiffness), and the secondary outcomes will be blood tests (including erythrocyte sedimentation rate, C-reactive protein, and rheumatoid factor) and adverse events. We will use Review Manager software to perform a meta-analysis, the Cochrane Collaboration \u201crisk of bias\u201d tool for assessing the risk of bias, and grades of recommendation, assessment, development and evaluation for the determination of the quality of evidence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration number:<\/jats:title>\n            <jats:p>\n                                 https:\/\/inplasy.com; INPLASY202230026.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We are going to investigate the effectiveness and safety of SXD for RA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study will provide reliable evidence on whether SXD is effective on RA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000029174","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:03:04Z","timestamp":1648742584000},"page":"e29174","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["The effectiveness and safety of Simiao Xiaobi decoction on rheumatoid arthritis"],"prefix":"10.1097","volume":"101","author":[{"given":"Soo-Yeon","family":"Chae","sequence":"first","affiliation":[{"name":"College of Korean Medicine, Dongguk University Graduate School, Seoul, Republic of Korea,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonju","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Physiology, College of Korean Medicine, Sangji University, Wonju-si, Gangwon-do, Republic of Korea,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Hee","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Acupuncture and Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonjusi, Gangwon-do, Republic of Korea,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Acupuncture & Moxibustion, Dongguk University Bundang Oriental Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Kwan","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Acupuncture & Moxibustion, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hyeon","family":"Baek","sequence":"additional","affiliation":[{"name":"Department of Acupuncture & Moxibustion, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Sik","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Sasang Constitutional Medicine, Dongguk University Bundang Oriental Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0585-9693","authenticated-orcid":false,"given":"Won-Suk","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Acupuncture & Moxibustion, Dongguk University Bundang Oriental Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis.","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbspin.2012.02.005","article-title":"Mortality in rheumatoid arthritis over the last fifty years: systematic review and metaanalysis.","volume":"80","author":"Dadoun","year":"2013","journal-title":"Joint Bone Spine"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study.","volume":"73","author":"Cross","year":"2014","journal-title":"Anne Rheum Dis"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis.","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R6-20250504","first-page":"1245","article-title":"Diagnosis and management of rheumatoid arthritis.","volume":"84","author":"Wasserman","year":"2011","journal-title":"Am Fam Physician"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.22783","article-title":"2015 American College of rheumatology guideline for the treatment of rheumatoid arthritis.","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"10018\u201331","DOI":"10.1002\/jcp.27860","article-title":"Strategies toward rheumatoid arthritis therapy; the old and the new.","volume":"234","author":"Abbasi","year":"2019","journal-title":"J Cell Physiol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","article-title":"Side effects of methotrexate therapy for rheumatoid arthritis: a systematic review.","volume":"158","author":"Wang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1586\/1744666X.2014.917963","article-title":"Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis.","volume":"10","author":"Moudgil","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"R11-20250504","first-page":"275","article-title":"Clinical study on active rheumatoid arthritis treated with Simiao Xiaobi decoction.","volume":"30","author":"Zhou","year":"2010","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.phytol.2018.11.019","article-title":"A new constituent against rheumatoid arthritis from the flower buds of Lonicera japonica.","volume":"29","author":"Xiao","year":"2019","journal-title":"Phytochem Lett"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"110735","DOI":"10.1016\/j.biopha.2020.110735","article-title":"Antitumor potential of Hedyotis diffusa Willd: a systematic review of bioactive constituents and underlying molecular mechanisms.","volume":"130","author":"Han","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12906-021-03252-y","article-title":"Clinical safety of total glucosides of paeony adjuvant therapy for rheumatoid arthritis treatment: a systematic review and meta-analysis.","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R17-20250504","first-page":"ED000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for systematic reviews of interventions.","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:07:56Z","timestamp":1746328076000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029174"}},"subtitle":["A study protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029174","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]},"assertion":[{"value":"2022-03-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}